Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-45.34%
operating margin TTM
-52.87%
revenue TTM
288.33 Thousand
revenue per share TTM
0.07$
valuation ratios | |
|---|---|
| pe ratio | -1.47 |
| peg ratio | 0.01 |
| price to book ratio | 0.57 |
| price to sales ratio | 0.74 |
| enterprise value multiple | 1.37 |
| price fair value | 0.57 |
profitability ratios | |
|---|---|
| gross profit margin | 59.32% |
| operating profit margin | -52.87% |
| pretax profit margin | -11.59% |
| net profit margin | -45.34% |
| return on assets | -18.08% |
| return on equity | -49.74% |
| return on capital employed | -32.82% |
liquidity ratios | |
|---|---|
| current ratio | 2.06 |
| quick ratio | 1.87 |
| cash ratio | 0.46 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 193.61 |
| operating cycle | 199.55 |
| days of payables outstanding | 235.39 |
| cash conversion cycle | -35.83 |
| receivables turnover | 61.39 |
| payables turnover | 1.55 |
| inventory turnover | 1.89 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.29 |
| debt equity ratio | 0.63 |
| long term debt to capitalization | 0.25 |
| total debt to capitalization | 0.39 |
| interest coverage | -1.78 |
| cash flow to debt ratio | -1.68 |
cash flow ratios | |
|---|---|
| free cash flow per share | -5.37 |
| cash per share | 7.13 |
| operating cash flow per share | -5.37 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.68 |
| short term coverage ratios | -4.73 |
| capital expenditure coverage ratio | -3,533.83 |
Frequently Asked Questions
When was the last time BioLineRx Ltd. (NASDAQ:BLRX) reported earnings?
BioLineRx Ltd. (BLRX) published its most recent earnings results on 24-11-2025.
What is BioLineRx Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioLineRx Ltd. (NASDAQ:BLRX)'s trailing twelve months ROE is -49.74%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioLineRx Ltd. (BLRX) currently has a ROA of -18.08%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BLRX's net profit margin stand at?
BLRX reported a profit margin of -45.34% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BLRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.06 in the most recent quarter. The quick ratio stood at 1.87, with a Debt/Eq ratio of 0.63.